Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Penzel

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Histopathology|April 22, 2005
Rheumatoid arthritis and pigmented villonodular synovitis: comparative analysis of cell polyploidy, cell cycle phases and expression of macrophage and fibroblast markers in proliferating synovial cellsI Berger, H Weckauf, B Helmchen, et al.
Journal of Clinical Pathology|February 25, 2006
Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40F Bergmann, S Aulmann, M N Wente, et al.
The British Journal of Dermatology|April 11, 2016
Anti-programmed cell death-1 therapy in nonmelanoma skin cancerJ K Winkler, R Schneiderbauer, C Bender, et al.
Human Genetics|November 10, 2001
Prenatal diagnosis and fetal pathology in a Turkish family harboring a novel nonsense mutation in the lysosomal alpha-N-acetyl-neuraminidase (sialidase) geneC Sergi, R Penzel, J Uhl, et al.
The Journal of Pathology|April 19, 2008
Abnormal crosstalk between pancreatic acini and macrophages during the clearance of apoptotic cells in chronic pancreatitisM Bartel, G M Hänsch, T Giese, et al.
The Journal of Pathology|February 2, 2006
Tenascin C and annexin II expression in the process of pancreatic carcinogenesisI Esposito, R Penzel, M Chaib-Harrireche, et al.
Cell Death and Differentiation|February 14, 2006
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptorsT Wenger, J Mattern, R Penzel, et al.
Der Pathologe|May 16, 2019
[From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?]J Leichsenring, D Kazdal, C Ploeger, et al.
Oncogenesis|May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, et al.
Der Pathologe|June 14, 2012
[BRAF mutation detection in metastatic melanoma]M Dietel, A Enk, A Lehmann, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Histopathology|April 22, 2005
Rheumatoid arthritis and pigmented villonodular synovitis: comparative analysis of cell polyploidy, cell cycle phases and expression of macrophage and fibroblast markers in proliferating synovial cellsI Berger, H Weckauf, B Helmchen, et al.
Journal of Clinical Pathology|February 25, 2006
Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40F Bergmann, S Aulmann, M N Wente, et al.
The British Journal of Dermatology|April 11, 2016
Anti-programmed cell death-1 therapy in nonmelanoma skin cancerJ K Winkler, R Schneiderbauer, C Bender, et al.
Human Genetics|November 10, 2001
Prenatal diagnosis and fetal pathology in a Turkish family harboring a novel nonsense mutation in the lysosomal alpha-N-acetyl-neuraminidase (sialidase) geneC Sergi, R Penzel, J Uhl, et al.
The Journal of Pathology|April 19, 2008
Abnormal crosstalk between pancreatic acini and macrophages during the clearance of apoptotic cells in chronic pancreatitisM Bartel, G M Hänsch, T Giese, et al.
The Journal of Pathology|February 2, 2006
Tenascin C and annexin II expression in the process of pancreatic carcinogenesisI Esposito, R Penzel, M Chaib-Harrireche, et al.
Cell Death and Differentiation|February 14, 2006
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptorsT Wenger, J Mattern, R Penzel, et al.
Der Pathologe|May 16, 2019
[From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?]J Leichsenring, D Kazdal, C Ploeger, et al.
Oncogenesis|May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, et al.
Der Pathologe|June 14, 2012
[BRAF mutation detection in metastatic melanoma]M Dietel, A Enk, A Lehmann, et al.
Pageof 4